Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
about
Management of cytomegalovirus infection and disease in liver transplant recipients.Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.Current concepts on cytomegalovirus infection after liver transplantationPolyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis.Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo.Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.Recent developments in human cytomegalovirus diagnosis.Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodiesEmergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies.Is prevention the best treatment? CMV after lung transplantation.Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro.Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.Cytomegalovirus infection after liver transplantation: current concepts and challenges.Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients.Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial.A survey of CMV prevention strategies after liver transplantation.Management of human cytomegalovirus infection in transplant recipients by the pre-emptive therapy approach
P2860
Q33845124-2349734C-4B0F-4AAF-88B6-14BC85409B40Q33950112-BE283D56-24E7-41A6-A2BC-9958A3AAF147Q34390310-54A37711-61CE-42A9-8EC1-6B7B9CBE74CCQ34605186-77764179-6F32-4C67-A9AE-0366A7ECB55CQ35845907-30D99B0C-7559-4B1E-A725-991A23059CD1Q35859879-7797E80E-96FE-42F2-8EA4-B50D027A1853Q36839729-E88487D3-D0B3-4036-B941-3F8A545FCB9DQ37196366-4E51C6D1-55CF-4C8A-8952-F06D4138B9CBQ37254190-BB11F73E-B335-4F9E-91E2-55D66B0953F7Q37304893-120BF6F8-3B7D-4658-9600-63EED5201749Q37612990-A1CFBB90-2F00-4428-83A6-42FAFB030A9BQ37778827-F0F6676E-6FC7-424B-AEA8-0FBD56DEB3F1Q37954420-2A0D3D7E-5F6C-4870-957E-710EFAB57ED8Q38908361-DB6530F9-5C7A-45AD-B6A1-E3080C91692DQ40483485-908E673E-D842-4BBB-A06E-3B7313269780Q42216221-2CD07EC9-0221-4807-9E6F-500314128B2EQ42549311-4C2B91B7-13C0-49E4-9D20-743B0E867871Q43489588-8490A2D7-2AFA-42BE-B3E1-CF7CE4B1BE01Q44407642-746161B0-B1BF-473A-AE2F-BCEA8B3E6799Q46921329-95A0D4E5-B4C2-44E6-AE2B-57EC49816479Q57275299-905E99BD-40C9-4475-BE57-EA3E8D98940D
P2860
Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cytomegalovirus infection in s ...... ons for preventive strategies.
@ast
Cytomegalovirus infection in s ...... ons for preventive strategies.
@en
type
label
Cytomegalovirus infection in s ...... ons for preventive strategies.
@ast
Cytomegalovirus infection in s ...... ons for preventive strategies.
@en
prefLabel
Cytomegalovirus infection in s ...... ons for preventive strategies.
@ast
Cytomegalovirus infection in s ...... ons for preventive strategies.
@en
P1476
Cytomegalovirus infection in s ...... ons for preventive strategies.
@en
P2093
Nina Singh
P304
P356
10.1016/J.JCV.2005.10.014
P577
2006-01-06T00:00:00Z